Generative Tensorial Networks Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Bankr. Admin/​Reorg

Generative Tensorial Networks General Information

Description

Provider of a drug discovery platform intended to transform drug discovery through interdisciplinary innovation. The company's platform combines quantum physics and machine learning algorithms to transform the search and discovery of patient-centered drugs, enabling researchers to discover new medicines that are more effective and affordable while accelerating the development process.

Contact Information

Website
www.gtn.ai
Formerly Known As
Qdiscovery
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 338 City Road
  • London EC1V 2PY
  • England, United Kingdom
Primary Industry
Drug Discovery
Vertical(s)
Artificial Intelligence & Machine Learning, TMT
Corporate Office
  • 338 City Road
  • London EC1V 2PY
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Generative Tensorial Networks Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Bankruptcy: Admin/Reorg 19-Mar-2020 Completed Bankruptcy: Admin/Reorg
3. Accelerator/Incubator 05-Aug-2019 Completed Startup
2. Seed Round 04-May-2018 $3.08M $3.18M Completed Startup
1. Accelerator/Incubator 15-Sep-2017 $104K $104K Completed Startup
To view Generative Tensorial Networks’s complete valuation and funding history, request access »

Generative Tensorial Networks Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
A Ordinary
A Ordinary
A Ordinary 21,888 $0.000140 $1.92 $1.92 1x $1.92 1.65%
A Ordinary 800 $0.013995 $53.71 $53.71 1x $53.71 0.06%
To view Generative Tensorial Networks’s complete cap table history, request access »

Generative Tensorial Networks Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of a drug discovery platform intended to transform drug discovery through interdisciplinary innovation. The com
Drug Discovery
London, United Kingdom

Austin, TX
 

Dublin, OH
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Generative Tensorial Networks Competitors (21)

One of Generative Tensorial Networks’s 21 competitors is MindWalk, a Corporation company based in Austin, TX.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MindWalk Corporation Austin, TX
Biosortia Microbiomics Venture Capital-Backed Dublin, OH
Editas Medicine Formerly VC-backed Cambridge, MA
HiFiBiO Therapeutics Venture Capital-Backed Cambridge, MA
Vir Biotechnology Formerly VC-backed San Francisco, CA
You’re viewing 5 of 21 competitors. Get the full list »

Generative Tensorial Networks Patents

  • 15

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

Generative Tensorial Networks Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201912405-D0 Transition state Inactive 29-Aug-2019
GB-201905870-D0 Graph pooling ii Inactive 26-Apr-2019
GB-201903995-D0 Graph pooling Inactive 22-Mar-2019
GB-201903945-D0 Q-graph ensemble Inactive 22-Mar-2019
GB-201819279-D0 Gtn big book 1a Inactive 27-Nov-2018
To view Generative Tensorial Networks’s complete patent history, request access »

Ready to get started?

Request a free trial

Generative Tensorial Networks FAQs

  • When was Generative Tensorial Networks founded?

    Generative Tensorial Networks was founded in 2017.

  • Where is Generative Tensorial Networks headquartered?

    Generative Tensorial Networks is headquartered in London, United Kingdom.

  • What industry is Generative Tensorial Networks in?

    Generative Tensorial Networks’s primary industry is Drug Discovery.

  • Is Generative Tensorial Networks a private or public company?

    Generative Tensorial Networks is a Private company.

  • What is Generative Tensorial Networks’s current revenue?

    The current revenue for Generative Tensorial Networks is .

  • How much funding has Generative Tensorial Networks raised over time?

    Generative Tensorial Networks has raised $3.18M.

  • Who are Generative Tensorial Networks’s competitors?

    MindWalk, Biosortia Microbiomics, Editas Medicine, HiFiBiO Therapeutics, and Vir Biotechnology are some of the 21 competitors of Generative Tensorial Networks.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process